What is the Plasminogen tissue activator?
The tissue plasminogen activator is emergency medicine provided to patients who have symptoms of active strokes or heart attacks. It works by melting the blood clots and thinning blood, which restores circulation into the brain and facilitates the heart of pumping blood throughout the body. When providing intravenous activator drugs for tissue of plasminogen, they perform extreme caution to prevent potentially fatal complications such as brain bleeding. When the medicine is administered in the first signs of the condition related to precipitation, it is usually very effective in solving problems before it causes permanent or life -threatening damage.
The blood vessels in the body naturally produce the type of plasminogen tissue activator that helps solve and prevent blood clots. In the case of a stroke or heart attack, however, there is not enough natural proteins to dissolve the main clot. The drugs of the Synthetic tissue of plasminogen provide enormous support for natural supply to the immediateEvřete clots and restore blood flow.
Kenka occurs when the brain does not get enough new oxygenated blood. Most cases are ischemic strokes caused by blood clots in the arteries between the brain and the heart. It is also possible to have a hemorrhagic stroke that is the result of a broken, leaked blood vessel in the brain. The use of the tissue plasminogen activator is only indicated when doctors are sure that the patient is suffering from ischemic stroke. Because blood is thinned, the drug may actually worsen the problem during the hemorrhagic stroke because it increases the amount of blood lost broken blood vessels.
Before administration of tissue plasminogen activator, the doctor carefully controls vital symptoms, reviews the patient's medical history and takes a number of diagnostic scans of the brain. Computer tomographic scanning is used to ensure symptoms of Being caused by ischemic stroke. If the tests confirm the blood clottedny, can be administered by a vein in the arm or leg. In the case of an advanced stroke that becomes a life -threatening, the catheter can be used to injure drugs directly into the clotted artery.
During the first three hours of the heart attack, patients may be administered by plasminogenic tissue activators to reduce the chance of imminent stroke. The distribution of clots, as soon as they begin to appear, helps prevent brain involvement and reduce heart muscle tissue damage. As with stroke victims, patients with a heart attack are thoroughly proven to prevent dangerous complications.